Induction of Fetal Lung Maturity with Corticosteroids: Which Evidence to Guide Clinical Practice?

Primary tabs

Acta Medica International,2015,2,1,177-179.
Published:January 2015
Type:Letter to Editor

Induction of Fetal Lung Maturity with Corticosteroids: Which Evidence to Guide Clinical Practice?

Antonio Simone Laganà1, Irene Condemi1, Vincenza Sofo2, Francesca Maria Salmeri2, Onofrio Triolo1
1Department of Pediatric, Gynecological, Microbiological and Biomedical Sciences, University of Messina, Messina, Italy.

2Departmentof Environmental Sciences, Safety, Territory, Food and Health,University of Messina, Messina, Italy

Abstract:

The clinical practice in maternal-fetal medicine is strongly infl uenced by the current management of the birth of a baby before a gestational age of 37 complete weeks, because of the high risks and complications (reversible or less) related to a premature birth, first of all Acute Respiratory Distress Syndrome (ARDS) and Intraventricular Haemorrhage (IVH). The relevant number of resources employed to reach a correct management of this kind of patients is pushing the health policy to develop a strong interest in evidence sourced from medical literature, with the aim to reduce the risk of adverse neonatal outcomes in case of premature birth. Read more.....

Keywords:Nil